Top compounds associated with response to BBS1


Feature Type Standardized
Nominal ANOVA
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.084 0.006
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.006
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.007
mRNA thalidomide CTRPv2 pan-cancer AAC 0.15 0.007
mRNA linifanib CTRPv2 pan-cancer AAC -0.097 0.008
mRNA Rapamycin gCSI pan-cancer AAC -0.14 0.01
mRNA IC-87114 CTRPv2 pan-cancer AAC -0.096 0.01
mRNA Curcumin CTRPv2 pan-cancer AAC -0.088 0.01
mRNA narciclasine CTRPv2 pan-cancer AAC -0.083 0.01
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.01
Download CSV